ARTICLE | Clinical News
LipoMASC liposome modification technology regulatory update
October 23, 2000 7:00 AM UTC
VLTS's PolyMASC Pharmaceuticals plc subsidiary (London, U.K.) received U.S. Patent No. 6,132,763 covering its LipoMASC technology that modifies the exterior of liposomes using polyethylene glycol (PEG...